FDA Inspection 698737 — Zhejiang Hisun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Hisun Pharmaceutical Co., Ltd. on Sep 9, 2010 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 9, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)